Moreover, non-disease-specific and non-invasive biomarkers of neuroaxonal and astroglial injury, such as neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) levels, can be widely applicable across leukodystrophies. The gene discussed is GFAP; the disease is leukodystrophy.